Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Neupro“
Suchtreffer
Begriffe & Kennungen
Neupro · 4.5 Interaction with other medicinal products and other forms of interaction · 4
Eintrag öffnenNeupro · 4.5 · 19 Co-administration of domperidone with rotigotine had no effect on the pharmacokinetics of rotigotine.
Eintrag öffnenNeupro · 4.5 · 5 Co-administration of L-dopa and carbidopa with rotigotine had no effect on the pharmacokinetics of rotigotin
Eintrag öffnenNeupro · 4.5 · Because rotigotine is a dopamine agonist, it is assumed that dopamine antagonists, such as neuroleptics (e.g.
Eintrag öffnenNeupro · 4.5 · Because rotigotine is a dopamine agonist, it is assumed that dopamine antagonists, such as neuroleptics (e.g.
Eintrag öffnenNeupro · 4.5 · Because rotigotine is a dopamine agonist, it is assumed that dopamine antagonists, such as neuroleptics (e.g.
Eintrag öffnenNeupro · 4.5 · Because rotigotine is a dopamine agonist, it is assumed that dopamine antagonists, such as neuroleptics (e.g.
Eintrag öffnenNeupro · 4.5 · Co-administration of L-dopa and carbidopa with rotigotine had no effect on the pharmacokinetics of rotigotine,
Eintrag öffnenNeupro · 4.5 · Co-administration of L-dopa and carbidopa with rotigotine had no effect on the pharmacokinetics of rotigotine,
Eintrag öffnenNeupro · 4.5 · Co-administration of L-dopa and carbidopa with rotigotine had no effect on the pharmacokinetics of rotigotine,
Eintrag öffnenNeupro · 4.5 · Co-administration of domperidone with rotigotine had no effect on the pharmacokinetics of rotigotine.
Eintrag öffnenNeupro · 4.5 · Co-administration of domperidone with rotigotine had no effect on the pharmacokinetics of rotigotine.
Eintrag öffnenNeupro · 4.5 · Co-administration of domperidone with rotigotine had no effect on the pharmacokinetics of rotigotine.
Eintrag öffnenNeupro · 4.5 · Co-administration of omeprazole (inhibitor of CYP2C19), in doses of 40 mg/day, had no effect on the pharmacoki
Eintrag öffnenNeupro · 4.5 · Co-administration of omeprazole (inhibitor of CYP2C19), in doses of 40 mg/day, had no effect on the pharmacoki
Eintrag öffnenNeupro · 4.5 · Co-administration of omeprazole (inhibitor of CYP2C19), in doses of 40 mg/day, had no effect on the pharmacoki
Eintrag öffnenNeupro · 4.5 · Co-administration of omeprazole (inhibitor of CYP2C19), in doses of 40 mg/day, had no effect on the pharmacoki
Eintrag öffnenNeupro · 4.5 · Co-administration of rotigotine (3 mg/24 h) did not affect the pharmacodynamics and pharmacokinetics of oral c
Eintrag öffnenNeupro · 4.5 · Co-administration of rotigotine (3 mg/24 h) did not affect the pharmacodynamics and pharmacokinetics of oral c
Eintrag öffnenNeupro · 4.5 · Co-administration of rotigotine (3 mg/24 h) did not affect the pharmacodynamics and pharmacokinetics of oral c
Eintrag öffnen